RAWEL

This brand name is authorized in Estonia, Croatia, Lithuania, Poland, Romania, United Kingdom

Active ingredients

The drug RAWEL contains one active pharmaceutical ingredient (API):

1 Indapamide UNII F089I0511L - INDAPAMIDE

Indapamide is a sulfonamide derivative with an indole ring, pharmacologically related to thiazide diuretics, which acts by inhibiting the reabsorption of sodium in the cortical dilution segment. It increases the urinary excretion of sodium and chlorides and, to a lesser extent, the excretion of potassium and magnesium, thereby increasing urine output and having an antihypertensive action. Read about Indapamide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C03BA11	Indapamide	C Cardiovascular system → C03 Diuretics → C03B Low-ceiling diuretics, excl. thiazides → C03BA Sulfonamides, plain
Discover more medicines within C03BA11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1185229, 1185230, 1185241, 1389854
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 167380
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-930275943
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004362, 1019803, 1019804, 1035420, 1058303
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100154639
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W43065001, W43065002, W43065003